As market values increase for computational biology and data science, biopharma companies are looking to hire R&D ...

In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...

Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s ...

Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal ...

Sangamo is on course to run out of money within months and has now lost access to up to $220 million in milestone payments ...